BIO - BIO-RAD LABORATORIES, INC.

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 282

Open

$ 279.39

Bid

$ 281.87 x 200

Ask

$ 0.00 x 0

Day's Range

$ 278.38 - $ 285.38

52 Week Range

$ 261.59 - $ 431.79

Volume

239,380

Average Volume

Market Cap

8.05B

Beta (5Y Monthly)

$ 0.85

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-08-2024	03-31-2024	10-Q
2	02-16-2024	12-31-2023	10-K
3	10-27-2023	09-30-2023	10-Q
4	08-04-2023	06-30-2023	10-Q
5	05-05-2023	03-31-2023	10-Q
6	02-17-2023	12-31-2022	10-K
7	10-28-2022	09-30-2022	10-Q
8	07-29-2022	06-30-2022	10-Q
9	04-29-2022	03-31-2022	10-Q
10	02-11-2022	12-31-2021	10-K
11	10-29-2021	09-30-2021	10-Q
12	07-30-2021	06-30-2021	10-Q
13	04-30-2021	03-31-2021	10-Q
14	02-16-2021	12-31-2020	10-K
15	10-30-2020	09-30-2020	10-Q
16	07-31-2020	06-30-2020	10-Q
17	05-08-2020	03-31-2020	10-Q
18	03-02-2020	12-31-2019	10-K
19	11-01-2019	09-30-2019	10-Q
20	08-06-2019	06-30-2019	10-Q
21	05-10-2019	03-31-2019	10-Q
22	04-01-2019	12-31-2018	10-K
23	11-05-2018	09-30-2018	10-Q
24	08-09-2018	06-30-2018	10-Q
25	05-10-2018	03-31-2018	10-Q
26	04-16-2018	12-31-2017	10-K
27	11-09-2017	09-30-2017	10-Q
28	08-07-2017	06-30-2017	10-Q
29	05-09-2017	03-31-2017	10-Q
30	03-01-2017	12-31-2016	10-K
31	11-02-2016	09-30-2016	10-Q
32	08-05-2016	06-30-2016	10-Q
33	05-06-2016	03-31-2016	10-Q
34	02-29-2016	12-31-2015	10-K
35	11-05-2015	09-30-2015	10-Q
36	08-07-2015	06-30-2015	10-Q
37	05-06-2015	03-31-2015	10-Q
38	03-02-2015	12-31-2014	10-K
39	11-07-2014	09-30-2014	10-Q
40	08-06-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

The Analyst Landscape: 4 Takes On Bio-Rad ...
05/08/2024 15:00:24

UBS Maintains Buy on Bio-Rad Laboratories,...
05/08/2024 13:15:59

UBS analyst Dan Leonard maintains Bio-Rad Laboratories (NYSE:BIO) with a Buy and lowers the price target from $420 to $385.

Bio-Rad Maintains Its FY24 Financial Outlook
05/07/2024 20:24:16

The company continues to expect non-GAAP, currency-neutral revenue growth of approximately 1.0 to 2.5 percent and an estimated ...

Bio-Rad Laboratories Q1 2024 Adj EPS $2.29...
05/07/2024 20:16:29

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.29 per share which beat the analyst consensus estimate of $2....

Bio-Rad Laboratories Inc Reports 8.99% Pas...
04/22/2024 17:35:46

- SEC Filing

96-of-sp-500-stocks-show-upside-potential-vs-street-estimates-which-offers-the-best-opportunity

96% Of S&P 500 Stocks Show Upside Potentia...
04/18/2024 17:01:41

480 out of 500 S&P 500 companies are trading below analysts' price targets, indicating potential profit opportunities. ...

Oncocyte Announces Partnership Agreement W...
04/11/2024 21:32:54

The new product is expected to launch in Q2 2024 to a select group of academic transplant centers in the US and EU and more bro...

Bio-Rad Laboratories Says Andrew Last, Exe...
04/10/2024 20:16:58

Last will remain part of Bio-Rad's executive leadership team to ensure a smooth transition while the company conducts a sea...

Citigroup Downgrades Bio-Rad Laboratories ...
04/03/2024 14:23:54

Citigroup analyst Patrick Donnelly downgrades Bio-Rad Laboratories (NYSE:BIO) from Buy to Neutral and lowers the price targe...

Bio-Rad Appoints Roop Lakkaraju As Executi...
03/20/2024 12:31:19

tech-stocks-ease-on-hot-ppi-yields-rise-microsoft-amazon-snap-5-week-positive-streak-whats-driving-markets-friday

Tech Stocks Ease On Hot PPI, Yields Rise, ...
02/16/2024 19:21:17

Wall Street takes pause after stronger-than-expected producer inflation report, potentially delaying Fed rate cuts and impactin...

RBC Capital Maintains Outperform on Bio-Ra...
02/16/2024 17:16:57

RBC Capital analyst Conor McNamara maintains Bio-Rad Laboratories (NYSE:BIO) with a Outperform and lowers the price target f...

Applied Materials Posts Upbeat Earnings, J...
02/16/2024 15:09:19

U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Friday.

Bio-Rad Laboratories: Q4 Earnings Insights
02/15/2024 21:20:19

Bio-Rad Laboratories Sees FY24 Non-GAAP Cu...
02/15/2024 21:18:11

Bio-Rad Laboratories Q4 2023 Adj EPS $3.10...
02/15/2024 21:16:48

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $3.10 per share which beat the analyst consensus estimate of $2....

Earnings Scheduled For February 15, 2024
02/15/2024 10:17:01

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on rev...

Preview: Bio-Rad Laboratories's Earnings
02/14/2024 19:01:27

10-sp-500-stocks-with-over-40-upside-potential-hidden-gems-or-value-traps

10 S&P 500 Stocks With Over 40% Upside Pot...
01/23/2024 18:12:27

S&P 500 index surges to new highs, driven by AI, earnings optimism, and Fed rate cuts. Top 10 stocks with significant upsid...

sp-500s-hidden-gems-27-stocks-with-30-upside-potential-according-to-wall-street-analyst-targets

S&P 500's Hidden Gems: 27 Stocks With 30%+...
12/07/2023 18:08:33

Fifty-six percent of S&P 500 companies have shown positive performance in 2023 and 44% retreated Moderna Inc. (NASDAQ: MRNA...